Atlas Trials

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Clinical trial NCT07659704 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07659704
Sponsor
University of Sao Paulo
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lupus Erythematosus, Systemic
Start date
2026-10-01
Primary completion
2027-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.